3,4-dihydroxyphenylacetic acid has been researched along with dutasteride in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al Sweidi, S; Bourque, M; Di Paolo, T; Litim, N; Morissette, M | 1 |
1 other study(ies) available for 3,4-dihydroxyphenylacetic acid and dutasteride
| Article | Year |
|---|---|
The 5α-reductase inhibitor Dutasteride but not Finasteride protects dopamine neurons in the MPTP mouse model of Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; 5-alpha Reductase Inhibitors; Animals; Corpus Striatum; Dihydrotestosterone; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopaminergic Neurons; Dose-Response Relationship, Drug; Dutasteride; Finasteride; Homovanillic Acid; Male; Mice, Inbred C57BL; MPTP Poisoning; Neuroprotective Agents; Pars Compacta; RNA, Messenger; Testosterone; Time Factors; Tyrosine 3-Monooxygenase; Vesicular Monoamine Transport Proteins | 2015 |